Free tool
Healthcare stocks
We cover 1,613 companies in the Healthcare sector. The median market value in the group is $479.91M, measured across the 1,000 largest of them. Among those 1,000, the median move over the past trading day is −0.23%. 50% of the 969 with a 200-day average trade above it. Price change over the past year runs from −44.0% to +108.1% across the middle 80 percent of the group, with a median of +4.3%. Among those 1,000, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
1,613 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| ABTT34.SA | Abbott Laboratories | $199.23B | Large cap | −16.35% |
| ABT | Abbott Laboratories | $198.74B | Large cap | −11.83% |
| GILD | Gilead Sciences, Inc. | $184.47B | Large cap | +32.51% |
| GIS.DE | Gilead Sciences, Inc. | $184.35B | Large cap | +33.64% |
| PFE | Pfizer Inc. | $161.30B | Large cap | +18.72% |
| PFE.DE | Pfizer Inc. | $161.11B | Large cap | +22.96% |
| DHER34.SA | Danaher Corporation | $151.72B | Large cap | +0.89% |
| DAP.DE | Danaher Corporation | $151.59B | Large cap | +6.90% |
| DHR | Danaher Corporation | $151.40B | Large cap | +5.61% |
| VX1.DE | Vertex Pharmaceuticals Incorporated | $139.82B | Large cap | +41.64% |
| VRTX | Vertex Pharmaceuticals Incorporated | $138.63B | Large cap | +40.66% |
| BMY | Bristol-Myers Squibb Company | $138.03B | Large cap | +47.01% |
| BRM.DE | Bristol-Myers Squibb Company | $137.92B | Large cap | +50.84% |
| ISRG | Intuitive Surgical, Inc. | $133.22B | Large cap | −21.38% |
| I1SR34.SA | Intuitive Surgical, Inc. | $132.60B | Large cap | −25.36% |
| IUI1.DE | Intuitive Surgical, Inc. | $131.98B | Large cap | −21.06% |
| SYK.DE | Stryker Corporation | $126.78B | Large cap | +34.90% |
| S1YK34.SA | Stryker Corporation | $126.60B | Large cap | −19.51% |
| SYK | Stryker Corporation | $126.45B | Large cap | −15.52% |
| MDT | Medtronic plc | $117.78B | Large cap | +2.29% |
| 2M6.DE | Medtronic plc | $117.57B | Large cap | +2.65% |
| SNW.DE | Sanofi | $109.40B | Large cap | −2.82% |
| SAN.PA | Sanofi | $109.36B | Large cap | −2.60% |
| SNY | Sanofi | $108.83B | Large cap | −4.33% |
| G1SK34.SA | GSK plc | $104.64B | Large cap | +27.31% |
| MCK | McKesson Corporation | $104.54B | Large cap | +31.57% |
| GSK | GSK plc | $104.29B | Large cap | +32.23% |
| GSK.L | GSK plc | $104.16B | Large cap | +30.59% |
| GS71.DE | GSK plc | $103.63B | Large cap | +34.79% |
| HCA | HCA Healthcare, Inc. | $94.76B | Large cap | +5.96% |
| A58.DE | Elevance Health, Inc. | $87.59B | Large cap | −19.30% |
| ELV | Elevance Health, Inc. | $87.30B | Large cap | +32.12% |
| E1LV34.SA | Elevance Health, Inc. | $86.53B | Large cap | +21.66% |
| ESL.DE | EssilorLuxottica Société anonyme | $85.76B | Large cap | −39.11% |
| EL.PA | EssilorLuxottica Société anonyme | $85.31B | Large cap | −38.15% |
| REGN34.SA | Regeneron Pharmaceuticals, Inc. | $85.16B | Large cap | +33.80% |
| REGN | Regeneron Pharmaceuticals, Inc. | $83.89B | Large cap | +39.36% |
| CGN.DE | The Cigna Group | $74.86B | Large cap | −8.78% |
| CI | The Cigna Group | $74.22B | Large cap | −4.84% |
| 4519.T | Chugai Pharmaceutical Co., Ltd. | $71.92B | Large cap | +9.21% |
| MRK.DE | Merck KGaA | $70.28B | Large cap | +32.17% |
| BSX | Boston Scientific Corporation | $69.81B | Large cap | −54.50% |
| BSX.DE | Boston Scientific Corporation | $69.12B | Large cap | −53.11% |
| M1RN34.SA | Moderna, Inc. | $63.51B | Large cap | +462.13% |
| COR | Cencora, Inc. | $62.55B | Large cap | +13.45% |
| MRNA | Moderna, Inc. | $59.75B | Large cap | +496.25% |
| TAK | Takeda Pharmaceutical Company Limited | $58.60B | Large cap | +22.68% |
| 4502.T | Takeda Pharmaceutical Company Limited | $58.08B | Large cap | +36.03% |
| BAYN.DE | Bayer Aktiengesellschaft | $56.25B | Large cap | +76.91% |
| BAY.WA | Bayer Aktiengesellschaft | $55.90B | Large cap | +76.59% |
| C1AH34.SA | Cardinal Health, Inc. | $55.77B | Large cap | +52.41% |
| CAH | Cardinal Health, Inc. | $55.45B | Large cap | +61.05% |
| 207940.KS | Samsung Biologics Co.,Ltd. | $53.31B | Large cap | +2.12% |
| EWL.DE | Edwards Lifesciences Corporation | $52.39B | Large cap | +11.65% |
| EW | Edwards Lifesciences Corporation | $52.32B | Large cap | +12.21% |
| 7741.T | HOYA Corporation | $51.57B | Large cap | +28.99% |
| SHL.DE | Siemens Healthineers AG | $51.23B | Large cap | −14.18% |
| E1WL34.SA | Edwards Lifesciences Corporation | $47.29B | Large cap | −4.72% |
| HUM | Humana Inc. | $46.96B | Large cap | +33.14% |
| H1UM34.SA | Humana Inc. | $46.72B | Large cap | +24.36% |
| MDLN | Medline Inc. | $46.53B | Large cap | −13.07% |
| RVMD | Revolution Medicines, Inc. | $46.18B | Large cap | +466.35% |
| H6D0.DE | Haleon plc | $44.85B | Large cap | +5.39% |
| HLN | Haleon plc | $44.72B | Large cap | +6.13% |
| HLN.L | Haleon plc | $44.62B | Large cap | +2.68% |
| I1DX34.SA | IDEXX Laboratories, Inc. | $44.35B | Large cap | −17.31% |
| TEVA | Teva Pharmaceutical Industries Limited | $44.19B | Large cap | +110.08% |
| IX1.DE | IDEXX Laboratories, Inc. | $44.14B | Large cap | +17.97% |
| A | Agilent Technologies, Inc. | $43.80B | Large cap | +31.46% |
| IDXX | IDEXX Laboratories, Inc. | $43.66B | Large cap | −13.64% |
| ONC | BeOne Medicines AG | $42.58B | Large cap | +25.21% |
| WAT | Waters Corporation | $40.67B | Large cap | +40.57% |
| 4578.T | Otsuka Holdings Co., Ltd. | $40.39B | Large cap | +57.62% |
| VEE.DE | Veeva Systems Inc. | $40.02B | Large cap | +13.43% |
| VEEV | Veeva Systems Inc. | $39.78B | Large cap | −16.58% |
| RPRX | Royalty Pharma plc | $35.71B | Large cap | +74.00% |
| 2U3.DE | Alcon Inc. | $35.20B | Large cap | −7.70% |
| ALC | Alcon Inc. | $35.13B | Large cap | −10.24% |
| RMD | ResMed Inc. | $34.13B | Large cap | −15.77% |
| RMD.AX | ResMed Inc. | $34.05B | Large cap | −24.75% |
| D1EX34.SA | DexCom, Inc. | $33.75B | Large cap | +9.64% |
| DXCM | DexCom, Inc. | $33.65B | Large cap | +16.47% |
| DC4.DE | DexCom, Inc. | $33.35B | Large cap | +21.06% |
| GEHC | GE HealthCare Technologies Inc. | $33.35B | Large cap | −1.15% |
| 4568.T | Daiichi Sankyo Company, Limited | $32.82B | Large cap | −17.94% |
| BIIB | Biogen Inc. | $32.66B | Large cap | +62.12% |
| C1NC34.SA | Centene Corporation | $32.65B | Large cap | +116.61% |
| IDP.DE | Biogen Inc. | $32.39B | Large cap | +65.32% |
| CNC | Centene Corporation | $32.34B | Large cap | +127.01% |
| DUL.DE | Alnylam Pharmaceuticals, Inc. | $32.28B | Large cap | −10.21% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $32.12B | Large cap | −47.38% |
| ZOE.DE | Zoetis Inc. | $32.08B | Large cap | −49.47% |
| ZTS | Zoetis Inc. | $32.03B | Large cap | −49.50% |
| Z1TS34.SA | Zoetis Inc. | $32.03B | Large cap | −52.31% |
| 068270.KS | Celltrion, Inc. | $31.91B | Large cap | +11.19% |
| A1LN34.SA | Alnylam Pharmaceuticals, Inc. | $31.78B | Large cap | −49.35% |
| FRE.DE | Fresenius SE & Co. KGaA | $30.43B | Large cap | +1.64% |
| BNTX | BioNTech SE | $28.28B | Large cap | +9.27% |
| MTD | Mettler-Toledo International Inc. | $28.10B | Large cap | +8.81% |
| MTO.DE | Mettler-Toledo International Inc. | $27.92B | Large cap | +13.15% |
| INSM | Insmed Incorporated | $27.16B | Large cap | −7.54% |
| 4503.T | Astellas Pharma Inc. | $26.88B | Large cap | +53.57% |
| ROIV | Roivant Sciences Ltd. | $26.55B | Large cap | +206.51% |
| PHG | Koninklijke Philips N.V. | $26.38B | Large cap | +1.27% |
| PHI1.DE | Koninklijke Philips N.V. | $26.37B | Large cap | +3.22% |
| INCY | Incyte Corporation | $25.97B | Large cap | +51.01% |
| WST | West Pharmaceutical Services, Inc. | $24.63B | Large cap | +42.61% |
| 4543.T | Terumo Corporation | $23.67B | Large cap | −2.68% |
| STE | STERIS plc | $23.09B | Large cap | −4.41% |
| GH | Guardant Health, Inc. | $22.94B | Large cap | +169.17% |
| THC | Tenet Healthcare Corporation | $21.89B | Large cap | +50.70% |
| DIM.PA | Sartorius Stedim Biotech S.A. | $21.78B | Large cap | +11.64% |
| 56S1.DE | Sartorius Stedim Biotech S.A. | $21.77B | Large cap | +11.32% |
| GMAB | Genmab A/S | $21.42B | Large cap | +36.20% |
| SRT3.DE | Sartorius Aktiengesellschaft | $19.68B | Large cap | +25.88% |
| VIA.DE | Viatris Inc. | $19.41B | Large cap | +67.32% |
| VTRS | Viatris Inc. | $19.35B | Large cap | +66.19% |
| ZBH | Zimmer Biomet Holdings, Inc. | $19.34B | Large cap | −4.32% |
| MEDP | Medpace Holdings, Inc. | $17.28B | Large cap | +30.74% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | $16.99B | Large cap | +61.26% |
| JAZZ | Jazz Pharmaceuticals plc | $16.89B | Large cap | +100.35% |
| ASND | Ascendis Pharma A/S | $16.41B | Large cap | +29.66% |
| IPN.PA | Ipsen S.A. | $15.97B | Large cap | +40.80% |
| COLO-B.CO | Coloplast A/S | $15.96B | Large cap | −20.60% |
| CBHD.DE | Coloplast A/S | $15.94B | Large cap | +7.91% |
| NBIX | Neurocrine Biosciences, Inc. | $15.92B | Large cap | +13.36% |
| SOLV | Solventum Corporation | $15.58B | Large cap | +25.57% |
| SRT.DE | Sartorius Aktiengesellschaft | $15.54B | Large cap | +21.79% |
| BBIO | BridgeBio Pharma, Inc. | $15.52B | Large cap | +60.05% |
| 4507.T | Shionogi & Co., Ltd. | $15.45B | Large cap | +15.63% |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | $15.44B | Large cap | +11.27% |
| RDOR3.SA | Rede D'Or São Luiz S.A. | $14.92B | Large cap | +1.37% |
| ESF0.DE | Eurofins Scientific SE | $14.67B | Large cap | +12.65% |
| 7733.T | Olympus Corporation | $14.46B | Large cap | +27.06% |
| COO | The Cooper Companies, Inc. | $14.25B | Large cap | −1.93% |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +45.68% |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +42.93% |
| BAX | Baxter International Inc. | $13.70B | Large cap | +8.90% |
| PME.AX | Pro Medicus Limited | $13.66B | Large cap | −39.15% |
| B1AX34.SA | Baxter International Inc. | $13.60B | Large cap | +3.61% |
| ORNBV.HE | Orion Oyj | $13.16B | Large cap | +21.01% |
| ORNAV.HE | Orion Oyj | $13.11B | Large cap | +21.27% |
| ICLR | ICON Public Limited Company | $13.03B | Large cap | −2.91% |
| CORT | Corcept Therapeutics Incorporated | $12.95B | Large cap | +71.81% |
| PEN | Penumbra, Inc. | $12.72B | Large cap | +21.02% |
| BMRN | BioMarin Pharmaceutical Inc. | $12.70B | Large cap | +11.85% |
| FME.DE | Fresenius Medical Care AG | $12.64B | Large cap | −2.61% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | $12.57B | Large cap | +1.80% |
| ELAN | Elanco Animal Health Incorporated | $12.53B | Large cap | +35.64% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $12.52B | Large cap | +308.99% |
| FMS | Fresenius Medical Care AG | $12.51B | Large cap | −3.21% |
| R1VT34.SA | Revvity, Inc. | $12.50B | Large cap | +22.81% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $12.45B | Large cap | +26.78% |
| TEM | Tempus AI, Inc. | $12.40B | Large cap | −6.49% |
| SNN | Smith & Nephew plc | $12.23B | Large cap | −19.49% |
| SN.L | Smith & Nephew plc | $12.18B | Large cap | −22.42% |
| EHC | Encompass Health Corporation | $11.92B | Large cap | −1.75% |
| DVAI34.SA | DaVita Inc. | $11.70B | Large cap | +18.80% |
| A1LG34.SA | Align Technology, Inc. | $11.51B | Large cap | +7.83% |
| DVA | DaVita Inc. | $11.41B | Large cap | +30.89% |
| SMMT | Summit Therapeutics Inc. | $11.35B | Large cap | −42.63% |
| TECH | Bio-Techne Corporation | $11.35B | Large cap | +29.33% |
| BTSG | BrightSpring Health Services, Inc. | $11.32B | Large cap | +156.37% |
| ALGN | Align Technology, Inc. | $11.31B | Large cap | +12.09% |
| AFW.DE | Align Technology, Inc. | $11.26B | Large cap | −54.37% |
| GMED | Globus Medical, Inc. | $11.16B | Large cap | +35.10% |
| CYTK | Cytokinetics, Incorporated | $11.01B | Large cap | +109.36% |
| AXSM | Axsome Therapeutics, Inc. | $10.85B | Large cap | +69.99% |
| I1QV34.SA | IQVIA Holdings Inc. | $10.82B | Large cap | −67.19% |
| GKOS | Glaukos Corporation | $10.65B | Large cap | +89.83% |
| KRYS | Krystal Biotech, Inc. | $10.65B | Large cap | +143.67% |
| MOH | Molina Healthcare, Inc. | $10.57B | Large cap | +13.35% |
| IONS | Ionis Pharmaceuticals, Inc. | $10.56B | Large cap | +48.21% |
| PRAX | Praxis Precision Medicines, Inc. | $10.54B | Large cap | +704.28% |
| UHS | Universal Health Services, Inc. | $10.53B | Large cap | −1.76% |
| KYMR | Kymera Therapeutics, Inc. | $10.53B | Large cap | +197.09% |
| ENSG | The Ensign Group, Inc. | $10.43B | Large cap | +5.01% |
| HSIC | Henry Schein, Inc. | $10.30B | Large cap | +31.02% |
| BIM.PA | bioMérieux S.A. | $10.22B | Large cap | −35.91% |
| ABVX.PA | ABIVAX Société Anonyme | $10.21B | Large cap | +48.91% |
| RDY | Dr. Reddy's Laboratories Limited | $10.18B | Large cap | −14.19% |
| ABVX | ABIVAX Société Anonyme | $10.17B | Large cap | +46.70% |
| RHCPA.AX | Ramsay Health Care Limited | $10.16B | Large cap | +1.45% |
| GHRS | GH Research PLC | $1.99B | Small cap | +112.84% |
| VIMIAN.ST | Vimian Group AB (publ) | $1.99B | Small cap | +12.01% |
| PIII | P3 Health Partners Inc. | $1.98B | Small cap | +26.37% |
| PGNY | Progyny, Inc. | $1.98B | Small cap | +14.55% |
| S1RP34.SA | Sarepta Therapeutics, Inc. | $1.98B | Small cap | −12.20% |
| FLRY3.SA | Fleury S.A. | $1.97B | Small cap | +37.82% |
| TSHA | Taysha Gene Therapies, Inc. | $1.96B | Small cap | +102.69% |
| EMBLA.CO | Embla Medical hf. | $1.93B | Small cap | −6.94% |
| GXE.DE | Lakefront Biotherapeutics NV | $1.93B | Small cap | −44.50% |
| IMCR | Immunocore Holdings plc | $1.93B | Small cap | +13.69% |
| ASTH | Astrana Health, Inc. | $1.92B | Small cap | +23.71% |
| LKFT | Lakefront Biotherapeutics NV | $1.91B | Small cap | −11.39% |
| SNDA | Sonida Senior Living, Inc. | $1.91B | Small cap | +51.53% |
| NTLA | Intellia Therapeutics, Inc. | $1.89B | Small cap | +15.50% |
| DMRA | Damora Therapeutics, Inc. | $1.89B | Small cap | +804.46% |
| SEPN | Septerna, Inc. | $1.88B | Small cap | +218.81% |
| NEU.AX | Neuren Pharmaceuticals Limited | $1.88B | Small cap | +5.54% |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.87B | Small cap | −28.63% |
| DRW8.DE | Drägerwerk AG & Co. KGaA | $1.84B | Small cap | +53.42% |
| SGRY | Surgery Partners, Inc. | $1.84B | Small cap | −38.48% |
| PSNL | Personalis, Inc. | $1.82B | Small cap | +257.32% |
| LMAT | LeMaitre Vascular, Inc. | $1.81B | Small cap | −16.20% |
| 4540.T | Tsumura & Co. | $1.79B | Small cap | +10.98% |
| INSP | Inspire Medical Systems, Inc. | $1.79B | Small cap | −33.04% |
| ATT.ST | Attendo AB (publ) | $1.77B | Small cap | +80.74% |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.77B | Small cap | +23.55% |
| FTRE | Fortrea Holdings Inc. | $1.76B | Small cap | +105.20% |
| ALVO | Alvotech | $1.75B | Small cap | −38.85% |
| ALVO-SDB.ST | Alvotech | $1.74B | Small cap | −39.57% |
| ANAB | AnaptysBio, Inc. | $1.73B | Small cap | +326.47% |
| ANIP | ANI Pharmaceuticals, Inc. | $1.71B | Small cap | −18.85% |
| MAZE | Maze Therapeutics, Inc. | $1.69B | Small cap | +113.27% |
| CLARI.PA | Clariane SE | $1.67B | Small cap | −6.95% |
| SIA.TO | Sienna Senior Living Inc. | $1.65B | Small cap | +25.96% |
| 7716.T | Nakanishi Inc. | $1.65B | Small cap | +52.27% |
| AVLN | Avalyn Pharma Inc. | $1.64B | Small cap | +25.60% |
| BCAX | Bicara Therapeutics Inc. | $1.64B | Small cap | +105.74% |
| 8129.T | Toho Holdings Co., Ltd. | $1.62B | Small cap | −24.33% |
| AGL | agilon health, inc. | $1.61B | Small cap | +194.58% |
| PYC.AX | PYC Therapeutics Limited | $1.60B | Small cap | +74.42% |
| 4DX.AX | 4DMedical Limited | $1.59B | Small cap | +669.79% |
| ARDT | Ardent Health, Inc. | $1.58B | Small cap | −11.64% |
| XERS | Xeris Biopharma Holdings, Inc. | $1.58B | Small cap | +8.64% |
| ABSI | Absci Corporation | $1.58B | Small cap | +261.57% |
| TRAX | First Tracks Biotherapeutics, Inc. | $1.58B | Small cap | +132.58% |
| AAPG | Ascentage Pharma Group Internat | $1.58B | Small cap | −59.18% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | $1.58B | Small cap | +298.89% |
| HCSG | Healthcare Services Group, Inc. | $1.57B | Small cap | +47.05% |
| 8086.T | Nipro Corporation | $1.57B | Small cap | +4.28% |
| BONEX.ST | Bonesupport Holding AB (publ) | $1.57B | Small cap | −28.26% |
| TYRA | Tyra Biosciences, Inc. | $1.56B | Small cap | +103.57% |
| KMTS | Kestra Medical Technologies, Ltd. | $1.56B | Small cap | +47.61% |
| LBRX | LB Pharmaceuticals Inc | $1.55B | Small cap | +178.41% |
| DIA.WA | Diagnostyka S.A. | $1.54B | Small cap | −17.76% |
| AVBP | ArriVent BioPharma, Inc. | $1.54B | Small cap | +62.10% |
| CNMD | CONMED Corporation | $1.53B | Small cap | −6.91% |
| INVA | Innoviva, Inc. | $1.53B | Small cap | +7.06% |
| OMCL | Omnicell, Inc. | $1.53B | Small cap | +0.66% |
| 4516.T | Nippon Shinyaku Co., Ltd. | $1.52B | Small cap | +19.48% |
| NVAX | Novavax, Inc. | $1.52B | Small cap | +21.50% |
| NOLA-B.ST | Nolato AB (publ) | $1.50B | Small cap | −7.00% |
| 6849.T | Nihon Kohden Corporation | $1.50B | Small cap | −7.26% |
| REPL | Replimune Group, Inc. | $1.50B | Small cap | +187.16% |
| TNDM | Tandem Diabetes Care, Inc. Common Stock | $1.49B | Small cap | +74.45% |
| RDC.DE | Redcare Pharmacy NV | $1.49B | Small cap | −23.82% |
| INNV | InnovAge Holding Corp. | $1.48B | Small cap | +178.79% |
| AKTS | Aktis Oncology, Inc. | $1.47B | Small cap | +18.35% |
| AZTA | Azenta, Inc. | $1.47B | Small cap | +11.16% |
| OMDA | Omada Health, Inc. | $1.47B | Small cap | +2.74% |
| PAHC | Phibro Animal Health Corporation | $1.46B | Small cap | +13.01% |
| SDGR | Schrödinger, Inc. | $1.46B | Small cap | −1.62% |
| ENOV | Enovis Corporation | $1.46B | Small cap | −18.60% |
| ATEC | Alphatec Holdings, Inc. | $1.45B | Small cap | −41.78% |
| ORIC | ORIC Pharmaceuticals, Inc. | $1.44B | Small cap | +35.58% |
| MGTX | MeiraGTx Holdings plc | $1.43B | Small cap | +100.54% |
| 4483.T | JMDC Inc. | $1.42B | Small cap | −17.21% |
| GDS.PA | Ramsay Générale de Santé SA | $1.42B | Small cap | +9.50% |
| IMTX | Immatics N.V. | $1.41B | Small cap | +74.63% |
| JBIO | Jade Biosciences, Inc. | $1.39B | Small cap | +168.30% |
| DRTS | Alpha Tau Medical Ltd. | $1.38B | Small cap | +343.92% |
| 3148.T | Create SD Holdings Co., Ltd. | $1.38B | Small cap | +1.90% |
| 9627.T | Ain Holdings Inc. | $1.38B | Small cap | +2.85% |
| VITR.ST | Vitrolife AB (publ) | $1.35B | Small cap | −30.23% |
| 3360.T | Ship Healthcare Holdings, Inc. | $1.35B | Small cap | +8.25% |
| NUTX | Nutex Health Inc. | $1.34B | Small cap | +118.22% |
| PNTG | The Pennant Group, Inc. | $1.34B | Small cap | +56.31% |
| UPR.L | Uniphar plc | $1.33B | Small cap | +6.94% |
| AORT | Artivion, Inc. | $1.33B | Small cap | −37.81% |
| AMN | AMN Healthcare Services, Inc. | $1.33B | Small cap | +70.26% |
| MLTX | MoonLake Immunotherapeutics | $1.32B | Small cap | −71.82% |
| REG.AX | Regis Healthcare Limited | $1.32B | Small cap | −20.05% |
| MNKD | MannKind Corporation | $1.32B | Small cap | −9.51% |
| IART | Integra LifeSciences Holdings Corporation | $1.31B | Small cap | +13.52% |
| VOR | Vor Biopharma Inc. | $1.30B | Small cap | −40.82% |
| SPI.L | Spire Healthcare Group plc | $1.28B | Small cap | +7.25% |
| RYM.AX | RYM FPO NZX [RYM] | $1.27B | Small cap | −27.80% |
| 4544.T | H.U. Group Holdings, Inc. | $1.26B | Small cap | +2.77% |
| SANA | Sana Biotechnology, Inc. | $1.25B | Small cap | +23.44% |
| GDRX | GoodRx Holdings, Inc. | $1.25B | Small cap | −18.89% |
| CERT | Certara, Inc. | $1.24B | Small cap | −25.07% |
| 2175.T | SMS Co., Ltd. | $1.24B | Small cap | +54.71% |
| ODTX | Odyssey Therapeutics, Inc. | $1.23B | Small cap | +56.03% |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.23B | Small cap | +207.92% |
| BIOG-B.ST | BioGaia AB (publ) | $1.23B | Small cap | +13.96% |
| CRVS | Corvus Pharmaceuticals, Inc. | $1.22B | Small cap | +167.82% |
| SNZ.AX | Summerset Group Holdings Limited | $1.22B | Small cap | −26.63% |
| 4553.T | Towa Pharmaceutical Co., Ltd. | $1.22B | Small cap | +34.65% |
| PRCT | PROCEPT BioRobotics Corporation | $1.21B | Small cap | −48.36% |
| CVSG.L | CVS Group plc | $1.20B | Small cap | +2.05% |
| 4887.T | Sawai Group Holdings Co., Ltd. | $1.18B | Small cap | −12.86% |
| AVNS | Avanos Medical Inc | $1.17B | Small cap | +110.53% |
| USPH | U.S. Physical Therapy, Inc. | $1.17B | Small cap | −5.67% |
| KURA | Kura Oncology, Inc. | $1.16B | Small cap | +66.16% |
| TDOC | Teladoc Health, Inc. | $1.15B | Small cap | −18.22% |
| SVRA | Savara Inc. | $1.15B | Small cap | +70.52% |
| LMRI | Lumexa Imaging Holdings, Inc. | $1.15B | Small cap | −35.42% |
| STAA | STAAR Surgical Company | $1.15B | Small cap | −16.90% |
| IVA.PA | Inventiva S.A. | $1.14B | Small cap | −14.63% |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | $1.14B | Small cap | +24.49% |
| IVA | Inventiva S.A. | $1.14B | Small cap | −7.84% |
| 2160.T | GNI Group Ltd. | $1.14B | Small cap | +8.36% |
| TTALO.HE | Terveystalo Oyj | $1.14B | Small cap | −22.31% |
| T2DH34.SA | Teladoc Health, Inc. | $1.13B | Small cap | −24.67% |
| SPH.WA | Sopharma AD | $1.13B | Small cap | −38.71% |
| IRMD | IRADIMED CORPORATION | $1.12B | Small cap | +19.80% |
| OPK | OPKO Health, Inc. | $1.11B | Small cap | +6.34% |
| 7476.T | AS ONE Corporation | $1.11B | Small cap | +2.31% |
| PHIL.MI | Philogen S.p.A. | $1.11B | Small cap | +4.75% |
| AVTX | Avalo Therapeutics, Inc. | $1.10B | Small cap | +112.95% |
| J2AZ34.SA | Jazz Pharmaceuticals plc | $1.08B | Small cap | +35.66% |
| 4547.T | Kissei Pharmaceutical Co., Ltd. | $1.06B | Small cap | −1.28% |
| 006280.KS | GC Biopharma Corp. | $1.06B | Small cap | −2.60% |
| SLDB | Solid Biosciences Inc. | $1.04B | Small cap | +72.95% |
| LXRX | Lexicon Pharmaceuticals, Inc. | $1.04B | Small cap | +104.42% |
| CSTL | Castle Biosciences, Inc. | $1.04B | Small cap | +52.96% |
| 069620.KS | Daewoong Pharmaceutical Co., Ltd | $1.03B | Small cap | −9.51% |
| WVE | Wave Life Sciences, Inc. | $1.03B | Small cap | −48.12% |
| ABUS | Arbutus Biopharma Corporation | $1.03B | Small cap | +42.19% |
| GUBRA.CO | Gubra A/S | $1.02B | Small cap | +4.79% |
| GXI.DE | Gerresheimer AG | $1.02B | Small cap | −39.73% |
| QDEL | QuidelOrtho Corporation | $1.02B | Small cap | −46.31% |
| MEDCL.PA | MedinCell S.A. | $1.02B | Small cap | +41.92% |
| PCRX | Pacira BioSciences, Inc. | $1.02B | Small cap | −0.88% |
| CADL | Candel Therapeutics, Inc. | $1.02B | Small cap | +124.70% |
| GERN | Geron Corporation | $995.83M | Small cap | +8.51% |
| 7730.T | Mani, Inc. | $994.58M | Small cap | +29.48% |
| DSGN | Design Therapeutics, Inc. | $975.65M | Small cap | +194.71% |
| VETO.PA | Vetoquinol SA | $973.12M | Small cap | −6.37% |
| BVS | Bioventus Inc. | $954.22M | Small cap | +86.52% |
| EUZ.DE | Eckert & Ziegler SE | $952.11M | Small cap | −24.60% |
| 4521.T | Kaken Pharmaceutical Co., Ltd. | $949.35M | Small cap | +10.07% |
| OLMA | Olema Pharmaceuticals, Inc. | $949.35M | Small cap | +89.02% |
| NEU.WA | NEUCA S.A. | $946.21M | Small cap | +15.02% |
| ANNX | Annexon, Inc. | $946.00M | Small cap | +136.49% |
| DBVT | DBV Technologies S.A. | $940.80M | Small cap | +53.00% |
| AMPH | Amphastar Pharmaceuticals, Inc. | $934.98M | Small cap | −27.78% |
| XVIVO.ST | Xvivo Perfusion AB (publ) | $929.27M | Small cap | +59.31% |
| CLYM | Climb Bio Inc | $923.57M | Small cap | +603.72% |
| PHN.MI | Pharmanutra S.p.A. | $921.01M | Small cap | +70.46% |
| 3046.T | JINS HOLDINGS Inc. | $911.23M | Small cap | −22.48% |
| ACRS | Aclaris Therapeutics, Inc. | $911.16M | Small cap | +240.11% |
| B2RK34.SA | Bruker Corporation | $906.52M | Small cap | +63.27% |
| DBV.PA | DBV Technologies S.A. | $901.25M | Small cap | +60.13% |
| CBLL | CeriBell, Inc. | $899.97M | Small cap | +102.16% |
| 4587.T | PeptiDream Inc. | $891.51M | Small cap | −27.31% |
| SGP | SpyGlass Pharma, Inc. | $891.05M | Small cap | +0.91% |
| ANL | Adlai Nortye Ltd. | $884.83M | Small cap | +791.12% |
| TBPH | Theravance Biopharma, Inc. | $884.18M | Small cap | +23.41% |
| SYNSAM.ST | Synsam AB (publ) | $873.75M | Small cap | +5.66% |
| 7780.T | Menicon Co., Ltd. | $873.71M | Small cap | +54.36% |
| TALK | Talkspace, Inc. | $870.57M | Small cap | +93.73% |
| BBNX | Beta Bionics, Inc. | $870.10M | Small cap | +1.95% |
| AVR | Anteris Technologies Global Corp. | $865.37M | Small cap | +144.54% |
| RIGL | Rigel Pharmaceuticals, Inc. | $864.97M | Small cap | +16.99% |
| INMD | InMode Ltd. | $864.89M | Small cap | −1.71% |
| MCAP.ST | MedCap AB (publ) | $864.73M | Small cap | −10.28% |
| SIBN | SI-BONE, Inc. | $861.71M | Small cap | +17.12% |
| AVR.AX | Anteris Technologies Global Corp. | $861.47M | Small cap | +106.39% |
| FDMT | 4D Molecular Therapeutics, Inc. | $859.60M | Small cap | +140.87% |
| COLL | Collegium Pharmaceutical, Inc. | $852.79M | Small cap | −29.08% |
| 4694.T | BML, Inc. | $851.50M | Small cap | +5.42% |
| DYVOX.ST | Dynavox Group AB (publ) | $850.75M | Small cap | −39.29% |
| AHG | Akso Health Group | $848.14M | Small cap | −43.10% |
| OXB.L | Oxford Biomedica plc | $847.14M | Small cap | −9.81% |
| PHAR | Pharming Group N.V. | $845.80M | Small cap | −14.47% |
| SLN | Silence Therapeutics plc | $840.94M | Small cap | +160.19% |
| HSTM | HealthStream, Inc. | $840.94M | Small cap | +1.86% |
| SFL.MI | Safilo Group S.p.A. | $839.99M | Small cap | +20.65% |
| AMS.L | Advanced Medical Solutions Group plc | $830.96M | Small cap | +38.01% |
| GNFT.PA | Genfit S.A. | $830.56M | Small cap | +310.45% |
| APOTEA.ST | Apotea AB (publ) | $822.73M | Small cap | −26.38% |
| ESPR | Esperion Therapeutics, Inc. Common Stock | $819.46M | Small cap | +45.87% |
| NVCT | Nuvectis Pharma, Inc. | $816.10M | Small cap | +275.94% |
| EIQ.AX | Echo IQ Limited | $814.45M | Small cap | +609.30% |
| WELL.TO | WELL Health Technologies Corp. | $807.72M | Small cap | −8.18% |
| ARJO-B.ST | Arjo AB (publ) | $802.95M | Small cap | −15.25% |
| AURA | Aura Biosciences, Inc. | $801.64M | Small cap | +20.03% |
| UU8.F | Neurogene Inc. | $795.50M | Small cap | +165.60% |
| STTK | Shattuck Labs, Inc. | $792.87M | Small cap | +690.00% |
| SNT.WA | Synektik Spólka Akcyjna | $774.15M | Small cap | +53.07% |
| NGNE | Neurogene Inc. | $768.64M | Small cap | +95.02% |
| 001067.KS | JW Pharmaceutical Corporation | $766.24M | Small cap | −23.16% |
| MNPR | Monopar Therapeutics Inc. | $763.31M | Small cap | +226.69% |
| DRUG | Bright Minds Biosciences Inc. | $751.90M | Small cap | +76.73% |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $751.23M | Small cap | −0.43% |
| D2OC34.SA | Doximity, Inc. | $733.94M | Small cap | −65.76% |
| 4534.T | Mochida Pharmaceutical Co., Ltd. | $730.42M | Small cap | +7.74% |
| CTMX | CytomX Therapeutics, Inc. | $723.43M | Small cap | +60.39% |
| OCS | Oculis Holding AG | $720.20M | Small cap | −25.14% |
| PHR | Phreesia, Inc. | $716.58M | Small cap | −63.74% |
| SSII | SS Innovations International, Inc. | $715.38M | Small cap | −50.55% |
| DHT-UN.TO | DRI Healthcare Trust | $714.70M | Small cap | +27.29% |
| XOMA | XOMA Royalty Corp | $710.16M | Small cap | +19.27% |
| PHAT | Phathom Pharmaceuticals, Inc. | $709.50M | Small cap | −29.50% |
| IRWD | Ironwood Pharmaceuticals, Inc. | $708.88M | Small cap | +240.48% |
| 9267.T | Genky DrugStores Co., Ltd. | $706.67M | Small cap | −20.07% |
| GYRE | Gyre Therapeutics, Inc. | $705.12M | Small cap | −18.00% |
| ALLO | Allogene Therapeutics, Inc. | $704.80M | Small cap | +75.86% |
| C2RS34.SA | CRISPR Therapeutics AG | $704.10M | Small cap | +0.85% |
| AGMB | AgomAb Therapeutics NV | $703.26M | Small cap | −2.53% |
| TECX | Tectonic Therapeutic, Inc. | $703.19M | Small cap | +35.43% |
| ZVRA | Zevra Therapeutics, Inc. | $697.17M | Small cap | +25.43% |
| EVT.DE | Evotec SE | $694.87M | Small cap | −45.75% |
| 7575.T | Japan Lifeline Co., Ltd. | $694.70M | Small cap | +12.02% |
| PROK | ProKidney Corp. | $694.58M | Small cap | −30.12% |
| EVO | Evotec SE | $693.01M | Small cap | −44.13% |
| GMRS | GMR Solutions Inc. | $692.56M | Small cap | −8.30% |
| GUD.TO | Knight Therapeutics Inc. | $690.78M | Small cap | +50.39% |
| DHT-U.TO | DRI Healthcare Trust | $690.34M | Small cap | +27.68% |
| EIKN | Eikon Therapeutics, Inc. | $679.77M | Small cap | −20.13% |
| CBIO | Crescent Biopharma, Inc. | $669.39M | Small cap | +26.46% |
| LBIRD.PA | Lumibird SA | $658.60M | Small cap | +57.43% |
| 2HQ0.DE | Tilray Brands, Inc. | $657.67M | Small cap | −67.56% |
| CRMD | CorMedix Inc. | $653.95M | Small cap | −40.66% |
| PRME | Prime Medicine, Inc. | $649.33M | Small cap | +4.37% |
| ANGO | AngioDynamics, Inc. | $648.51M | Small cap | +56.74% |
| 4565.T | Nxera Pharma Co., Ltd. | $648.21M | Small cap | +22.68% |
| MDXG | MiMedx Group, Inc. | $644.26M | Small cap | −38.35% |
| VSTM | Verastem, Inc. | $641.19M | Small cap | −20.45% |
| TLRY.TO | Tilray Brands, Inc. | $640.36M | Small cap | +240.00% |
| CTNM | Contineum Therapeutics, Inc. | $640.31M | Small cap | +70.03% |
| KIDS | OrthoPediatrics Corp. | $639.69M | Small cap | +11.10% |
| IDX.AX | Integral Diagnostics Limited | $638.89M | Small cap | −19.60% |
| 185750.KS | Chong Kun Dang Pharmaceutical Corp. | $638.45M | Small cap | −16.94% |
| TLRY | Tilray Brands, Inc. | $638.38M | Small cap | −66.13% |
| CTEV | Claritev Corporation | $636.72M | Small cap | −47.71% |
| 6197.T | Solasto Corporation | $635.28M | Small cap | +136.68% |
| VALN | Valneva SE | $634.84M | Small cap | −23.49% |
| DASA3.SA | Diagnósticos da América S.A. | $633.57M | Small cap | +93.33% |
| CU6.AX | Clarity Pharmaceuticals Ltd | $628.73M | Small cap | −25.63% |
| VLA.PA | Valneva SE | $627.96M | Small cap | −24.48% |
| AUTL | Autolus Therapeutics plc | $620.16M | Small cap | +48.41% |
| AYJ.DE | Valneva SE | $619.77M | Small cap | −21.89% |
| ARVN | Arvinas, Inc. | $609.40M | Small cap | +15.35% |
| ALT | Altimmune, Inc. | $604.95M | Small cap | −14.17% |
| MPLT | MapLight Therapeutics, Inc. | $596.42M | Small cap | −29.88% |
| CTKB | Cytek Biosciences, Inc. | $594.02M | Small cap | +11.74% |
| 3034.T | Qol Holdings Co., Ltd. | $588.82M | Small cap | +24.35% |
| RGNX | REGENXBIO Inc. | $588.18M | Small cap | +6.35% |
| CRW.L | Craneware plc | $588.10M | Small cap | −40.83% |
| EQS.PA | Equasens Société anonyme | $588.00M | Small cap | −25.98% |
| WEAV | Weave Communications, Inc. | $584.79M | Small cap | −5.68% |
| EOLS | Evolus, Inc. | $579.92M | Small cap | +15.83% |
| ARTV | Artiva Biotherapeutics, Inc. | $575.44M | Small cap | +259.94% |
| BWAY | BrainsWay Ltd. | $574.70M | Small cap | +87.42% |
| 4559.T | Zeria Pharmaceutical Co., Ltd. | $574.42M | Small cap | +3.91% |
| ZURA | Zura Bio Limited | $574.02M | Small cap | +177.31% |
| DCTH | Delcath Systems, Inc. | $569.06M | Small cap | +49.91% |
| SPRY | ARS Pharmaceuticals, Inc. | $568.84M | Small cap | −55.13% |
| RAY-B.ST | RaySearch Laboratories AB (publ) | $564.79M | Small cap | −29.98% |
| OVID | Ovid Therapeutics Inc. | $562.46M | Small cap | +128.57% |
| EVH | Evolent Health, Inc. | $556.25M | Small cap | −48.86% |
| ENTX | Entera Bio Ltd. | $552.32M | Small cap | +62.76% |
| CERS | Cerus Corporation | $552.18M | Small cap | +109.16% |
| 005257.KS | GC Corp. | $547.34M | Small cap | −40.16% |
| 003850.KS | Boryung Corporation | $547.03M | Small cap | +9.00% |
| KYTX | Kyverna Therapeutics, Inc. | $546.70M | Small cap | +133.33% |
| CABA | Cabaletta Bio, Inc. | $545.94M | Small cap | +116.67% |
| FLGT | Fulgent Genetics, Inc. | $545.08M | Small cap | −8.46% |
| SRTA | Strata Critical Medical, Inc. | $541.42M | Small cap | +33.62% |
| AYA.AX | Artrya Limited | $539.15M | Small cap | +157.95% |
| TCMD | Tactile Systems Technology, Inc. | $532.56M | Small cap | +78.78% |
| 2664.T | Cawachi Limited | $531.16M | Small cap | +38.25% |
| 137310.KS | SD Biosensor, Inc. | $525.90M | Small cap | −38.35% |
| 003090.KS | Daewoong Co., Ltd. | $525.82M | Small cap | −27.35% |
| BOI.PA | Boiron SA | $523.06M | Small cap | +21.99% |
| CCCC | C4 Therapeutics, Inc. | $521.63M | Small cap | +64.34% |
| 019175.KS | Shinpoong Pharmaceutical Co.,Ltd | $517.68M | Small cap | −40.58% |
| 7979.T | Shofu Inc. | $517.24M | Small cap | +21.34% |
| 4480.T | Medley, Inc. | $512.99M | Small cap | +9.22% |
| TOI | Starling Oncology Inc | $512.91M | Small cap | +79.19% |
| DNA | Ginkgo Bioworks Holdings, Inc. | $507.75M | Small cap | −41.46% |
| NPCE | NeuroPace, Inc. | $503.88M | Small cap | +65.32% |
| 3151.T | Vital KSK Holdings, Inc. | $501.27M | Small cap | +40.44% |
| EVMN | Evommune, Inc. | $500.47M | Small cap | −30.25% |
| CLPT | ClearPoint Neuro, Inc. | $499.35M | Small cap | +53.85% |
| IMR.AX | Imricor Medical Systems, Inc. | $498.58M | Small cap | +40.43% |
| J8J.F | TransThera Sciences (Nanjing), Inc. | $498.50M | Small cap | −90.91% |
| 4592.T | SanBio Company Limited | $495.75M | Small cap | −57.08% |
| ALVIO.PA | Valerio Therapeutics Société anonyme | $492.64M | Small cap | +1198.08% |
| CGC | Canopy Growth Corporation | $492.21M | Small cap | −31.46% |
| EPRX | Eupraxia Pharmaceuticals Inc. | $490.26M | Small cap | +40.72% |
| WEED.TO | Canopy Growth Corporation | $489.98M | Small cap | −31.25% |
| EDIT | Editas Medicine, Inc. | $488.38M | Small cap | +19.10% |
| EPRX.TO | Eupraxia Pharmaceuticals Inc. | $487.17M | Small cap | +43.78% |
| NRC | NRC Health | $487.06M | Small cap | +45.92% |
| 4549.T | Eiken Chemical Co., Ltd. | $486.14M | Small cap | −5.16% |
| RLMD | Relmada Therapeutics, Inc. | $485.35M | Small cap | +579.10% |
| RZLT | Rezolute, Inc. | $485.31M | Small cap | −30.00% |
| PNV.AX | PolyNovo Limited | $485.11M | Small cap | −23.99% |
| PACB | Pacific Biosciences of California, Inc. | $484.90M | Small cap | +17.29% |
| KMDA | Kamada Ltd. Ordinary Shares | $483.48M | Small cap | +21.09% |
| 317450.KS | MYUNGIN PHARM | $482.84M | Small cap | −55.96% |
| CAPR | Capricor Therapeutics, Inc. | $481.97M | Small cap | +49.76% |
| AGY.L | Allergy Therapeutics plc | $481.91M | Small cap | −30.00% |
| PGMN3.SA | Empreendimentos Pague Menos S.A. | $481.69M | Small cap | −1.57% |
| QTTB | Q32 Bio Inc. | $481.67M | Small cap | +840.70% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.